Clinical trial
Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD)…
NCT00096915 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00096915 |
|---|---|
| Title | Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis |
| Official title | A Multicenter, Single-Arm Study Evaluating Once Monthly Darbepoetin Alfa Dosing in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Disease, Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | Darbepoetin Alfa |
| Enrollment | 110 |
| Start date | Oct 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Nov 18, 2004 |
| Last update posted | May 22, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: